Publications
- The analysis of factors affecting the threshold on repeated F-18-FDG-PET/CT investigations measured by the PERCIST protocol in patients with esophageal carcinoma2012 | First Faculty of Medicine
- Gefitinib monotherapy in advanced non-small cell lung cancer harboring activating mutation of EGFR had significantly better treatment results comparing to standard chemotherapy - from clinical practice2010 | First Faculty of Medicine
- Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up2010 | First Faculty of Medicine
- Concurrent Versus Sequential Radiochemotherapy With Vinorelbine Plus Cisplatin (V-P) In Locally Advanced Non-small Cell Lung cancer. A randomized phase II study - long-term follow-up data2003 | First Faculty of Medicine
- Gencitabine plus Cisplatin versus Gemcitabine plus carboplatin in Stage IIIb and IV Non. Small Cell Lung Cancer: A Phase III Randomized TrialPublication without faculty affiliation
- Case reports of patients with ALK-positive NSCLC and brain metastases2023 | First Faculty of Medicine
- Současné místo trastuzumab deruxtecanu v léčbě karcinomu žaludku a gastroezofageální junkce2023 | First Faculty of Medicine
- Treatment of lung cancer with targetable mutations - new drugs and indications2023 | First Faculty of Medicine
- Malignant pleural mesothelioma – case report2023 | First Faculty of Medicine
- Adjuvantní léčba anti-EGFR tyrosinkinázovými inhibitory u resekovaného NSCLC a studie ADAURA – komentář2023 | First Faculty of Medicine
Loading network view...
